Abacavir, dolutegravir, and lamivudine and Claforan in D5W
Determining the interaction of Abacavir, dolutegravir, and lamivudine and Claforan in D5W and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: abacavir / dolutegravir / lamivudine
Brand name: Triumeq
Synonyms: Abacavir, Dolutegravir, and Lamivudine
Generic Name: cefotaxime
Brand name: Claforan, Claforan ADD-Vantage
Synonyms: Claforan
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Abacavir, dolutegravir, and lamivudine-Claravis
- Abacavir, dolutegravir, and lamivudine-Clarifoam EF
- Abacavir, dolutegravir, and lamivudine-Clarinex
- Abacavir, dolutegravir, and lamivudine-Clarinex (Desloratadine Syrup)
- Abacavir, dolutegravir, and lamivudine-Clarinex (Desloratadine Tablets)
- Abacavir, dolutegravir, and lamivudine-Clarinex Reditabs
- Claforan in D5W-Abacavir, Lamivudine and Zidovudine Tablets
- Claforan in D5W-Abacavir, lamivudine, and zidovudine
- Claforan in D5W-Abaloparatide
- Claforan in D5W-Abaloparatide Subcutaneous
- Claforan in D5W-Abatacept
- Claforan in D5W-Abatacept Auto-Injectors